Immunochemotherapy against a nerve growth factor producing tumor (S-180) using anti-NGF IgG as a carrier for adriamycin.
D000818:Animals; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D009414:Nerve Growth Factors / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000628:therapy*
D007074:Immunoglobulin G; D009414:Nerve Growth Factors; D004317:Doxorubicin